Literature DB >> 9932220

Chronic diarrhoea and diabetes mellitus: prevalence of small intestinal bacterial overgrowth.

M Virally-Monod1, D Tielmans, J P Kevorkian, Y Bouhnik, B Flourie, B Porokhov, C Ajzenberg, A Warnet, P J Guillausseau.   

Abstract

The mechanisms of chronic diarrhoea, a frequent symptom in diabetes mellitus, are multifactorial and complex, although small intestinal bacterial overgrowth and autonomic neuropathy seem to play a major role. This study evaluated the prevalence of small intestinal bacterial overgrowth and the effects of antibiotic treatment in a population of diabetic patients with chronic diarrhoea (defined as > 3 stools/24 h, weight > 200 g/24 h, duration > 3 weeks). Small intestinal bacterial overgrowth syndrome was diagnosed by glucose-hydrogen breath testing (sensitivity: 78%, specificity: 89%). The characteristics of diarrhoea (duration, number of stools per day, and gastrointestinal symptoms) were noted. Autonomic neuropathy was assessed by cardiac parasympathetic tests. A total of 35 patients were included, 15 with small intestinal bacterial overgrowth syndrome (43%, group 1) and 20 with no bacterial overgrowth (group 2). Age (52.9 +/- 13.5 vs. 53.9 +/- 11.8 years, NS), duration of diabetes (13.8 +/- 9.1 vs. 10.6 +/- 7.8 years, NS), and HbA1c level (10 +/- 2.9 vs. 10.9 +/- 2.4%, NS) were not different between the two groups. In group 1, duration of diarrhoea was longer (18.1 +/- 18.5 vs. 7.75 +/- 4.02 months, P = 0.05), the number of stools higher (7.1 +/- 5.7 vs. 4.6 +/- 2.6/24 h, P < 0.05), and gastrointestinal symptoms more frequent (13 vs. 10, P < 0.05). The prevalence of small intestinal bacterial overgrowth syndrome and gastrointestinal symptoms was not different in patients with and without autonomic neuropathy (9 vs. 8 and 12 vs. 11 respectively, NS). Eight patients with bacterial overgrowth received antibiotics (amoxicillin-clavulanic acid, 1.5 g/24 h for 10 days). Dramatic clinical improvement was observed in 6 out of 8 of these patients. It is concluded that small intestinal bacterial overgrowth should be considered in case of chronic diabetic diarrhoea because of its frequency (43%), facility of diagnosis, and often successful treatment with antibiotics.

Entities:  

Mesh:

Year:  1998        PMID: 9932220

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  22 in total

1.  Small Bowel Bacterial Overgrowth: Presentation, Diagnosis, and Treatment.

Authors:  Virmeet V. Singh; Phillip P. Toskes
Journal:  Curr Treat Options Gastroenterol       Date:  2004-02

2.  Gas and Bloating.

Authors:  William L Hasler
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-09

Review 3.  Mechanisms Linking the Gut Microbiome and Glucose Metabolism.

Authors:  Kristina M Utzschneider; Mario Kratz; Chris J Damman; Meredith Hullar
Journal:  J Clin Endocrinol Metab       Date:  2016-03-03       Impact factor: 5.958

Review 4.  Small intestinal bacterial overgrowth syndrome.

Authors:  Jan Bures; Jiri Cyrany; Darina Kohoutova; Miroslav Förstl; Stanislav Rejchrt; Jaroslav Kvetina; Viktor Vorisek; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

5.  Small intestinal bacterial overgrowth: a comprehensive review.

Authors:  Andrew C Dukowicz; Brian E Lacy; Gary M Levine
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-02

6.  Type 1 diabetic patients with peripheral neuropathy have pan-enteric prolongation of gastrointestinal transit times and an altered caecal pH profile.

Authors:  Adam D Farmer; Anne Grave Pedersen; Birgitte Brock; Poul Erik Jakobsen; Jesper Karmisholt; Sahar D Mohammed; S Mark Scott; Asbjørn Mohr Drewes; Christina Brock
Journal:  Diabetologia       Date:  2017-01-20       Impact factor: 10.122

Review 7.  Complications associated with new-onset diabetes after kidney transplantation.

Authors:  Adnan Sharif; Keshwar Baboolal
Journal:  Nat Rev Nephrol       Date:  2011-11-15       Impact factor: 28.314

Review 8.  The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.

Authors:  Mehmet Kanbay; Emine M Onal; Baris Afsar; Tuncay Dagel; Aslihan Yerlikaya; Adrian Covic; Nosratola D Vaziri
Journal:  Int Urol Nephrol       Date:  2018-05-04       Impact factor: 2.370

9.  Restoration of Na+/H+ exchanger NHE3-containing macrocomplexes ameliorates diabetes-associated fluid loss.

Authors:  Peijian He; Luqing Zhao; Lixin Zhu; Edward J Weinman; Roberto De Giorgio; Michael Koval; Shanthi Srinivasan; C Chris Yun
Journal:  J Clin Invest       Date:  2015-08-10       Impact factor: 14.808

10.  Gastrointestinal complications of diabetes mellitus.

Authors:  Babu Krishnan; Shithu Babu; Jessica Walker; Adrian B Walker; Joseph M Pappachan
Journal:  World J Diabetes       Date:  2013-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.